Skip to main content
Clinical Trials/NCT05038579
NCT05038579
Completed
N/A

Clinical Validation of a Cognitive Stimulation Platform for Individuals With Dementia - Musiquence

Universidade da Madeira1 site in 1 country13 target enrollmentSeptember 1, 2019
ConditionsDementia

Overview

Phase
N/A
Intervention
Not specified
Conditions
Dementia
Sponsor
Universidade da Madeira
Enrollment
13
Locations
1
Primary Endpoint
Mini-Mental State Examination (Cognitive Screening) (MMSE)
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Dementia is a neurodegenerative syndrome that leads to cognitive deficits and, consequently, affects functionality and quality of life.

This study will explore the clinical impact of a customized cognitive stimulation program, using Musiquence.

Detailed Description

Dementia is a clinical syndrome characterized by a progressive and irreversible deterioration of cognitive functioning that impairs behavioral and functional domains. Within non-pharmacological approaches, Cognitive Stimulation Therapy (CST) is the most studied and well-established intervention for individuals with mild to moderate dementia. The underlying assumptions behind cognitive-based interventions of CST are: 1. IwD can benefit from cognitive stimulation if mobilized relatively preserved cognitive functions (e.g., crystallized abilities such as semantic memory and verbal skills), and; 2. Even in advanced age, exposure to enriched environments (i.e., socially and cognitively challenging) can enhance cognitive reserve and neuroplasticity. Concerning the first assumption of cognitive-based interventions (a1), it is known that even in moderate to advanced stages of dementia, musical memory is one of the abilities that remain intact. It is hypothesized that music processing abilities precede the development of lexical language functions. This hypothesis is corroborated by findings that demonstrate that IwD are still responsive to music even when unable to communicate verbally or recognize words. Additionally, music is frequently associated with life experiences. Also, literature has reported that memories associated with specific music would be recollected longer than memories with no association to music; this suggests that using music as a reminiscence element on cognitive stimulation programs can have a promising effect on cognition. According to the second assumption of CST (a2), facilitating an enriching environment for IwD using, for , music and reminiscence elements could impact cognitive reserve and neuroplasticity. In this context, Ferreira et al. developed a platform - Musiquence - that incorporates music and reminiscence in cognitive stimulation activities for IwD. Musiquence allows the gamification and personalization of 6 types of activities: * Reality Orientation - a quiz-like activity that includes date and time information. * Creative Drawings - a puzzle-like game in which the participant draws the missing pieces. * Activities of Daily Living (ADL) - a puzzle-like game in which the participants have to perform a set of chores (i.e., brush the teeth), and the missing pieces are completed with real physical objects (i.e., toothpaste). * Search Objects activity - exploration game in which the participants must find hidden images (e.g., cats) that are only visible through a virtual magnifying glass. * Knowledge Quiz - participants must select the correct answer to a question among incorrect ones. * Association activity - participants must categorize the items according to the instructions. For example, separate cars from motorcycles and locate them in the correct container. The platform is compatible with different technologies that allow adaptation to the patients' needs (motor difficulties, vision problems, tremble). Cognitive stimulation content can be personalized to the user since the caregivers can add text, images, and music when creating the tasks.

Registry
clinicaltrials.gov
Start Date
September 1, 2019
End Date
February 28, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sergi Bermúdez i Badia

Associate Professor at the University of Madeira and Senior Researcher at NOVA-LINCS

Universidade da Madeira

Eligibility Criteria

Inclusion Criteria

  • Mild to moderate stage of dementia (with formal diagnosis);
  • Ability to move upper limbs;
  • Maintained auditory acuity;
  • Relatively preserved language skills.

Exclusion Criteria

  • Moderate to severe depressive symptomatology;
  • Moderate to severe anxious symptomatology;
  • Bedridden.

Outcomes

Primary Outcomes

Mini-Mental State Examination (Cognitive Screening) (MMSE)

Time Frame: Baseline, Post-intervention (7 weeks), Follow-up (3 months)

Change from baseline in the MMSE. Minimum of 0 points and maximum of 30 points. Higher scores mean better outcomes.

Alzheimer's Disease Assessment Scale - Cognitive Scale (ADAS - Cog)

Time Frame: Baseline, Post-intervention (7 weeks), Follow-up (3 months)

Change from baseline in the ADAS-Cog. Minimum of 0 points and maximum of 68 points. Higher scores mean worse outcomes.

Secondary Outcomes

  • Quality of Life - Alzheimer's Disease (QoL - AD)(Baseline, Post-intervention (7 weeks), Follow-up (3 months))
  • Kettler Laurent Thierreau (KLT)(Baseline, Post-intervention (7 weeks), Follow-up (3 months))
  • Symbol Search - Weschler Adult Inteligence Scale 3rd edition (SR)(Baseline, Post-intervention (7 weeks), Follow-up (3 months))
  • Rating Anxiety in Dementia (RAID) scale.(Baseline, Post-intervention (7 weeks), Follow-up (3 months))
  • Semantic and Phonemic Verbal Fluency (SPVF)(Baseline, Post-intervention (7 weeks), Follow-up (3 months))
  • Digital Symbol Coding - Weschler Adult Inteligence Scale 3rd edition (DSC)(Baseline, Post-intervention (7 weeks), Follow-up (3 months))
  • Cornell Scale for Depression in Dementia(Baseline, Post-intervention (7 weeks), Follow-up (3 months))
  • Adults and Older Adults Functional Assessment Inventory (IAFAI)(Baseline, Post-intervention (7 weeks), Follow-up (3 months))

Study Sites (1)

Loading locations...

Similar Trials